miRNAs mediated drug resistance in hematological malignancies
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference264 articles.
1. Special issue: new approaches to counteract drug resistance in cancer;Vasconcelos;Molecules,2016
2. Understanding cancer drug resistance by developing and studying resistant cell line models;Xavier;Curr. Cancer Drug Targets,2016
3. Drug resistance in cancer: an overview;Housman;Cancers (Basel),2014
4. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance;Vasconcelos;Drug Resist. Updat.,2019
5. The multi-factorial nature of clinical multidrug resistance in cancer;Assaraf;Drug Resist. Updat.,2019
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy;Current Drug Delivery;2024-03
2. Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels;Medical Oncology;2024-01-12
3. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance;Reference Module in Biomedical Sciences;2024
4. Exploring the Regulatory Roles of miR-21, miR-15, and miR-let-7 in ABC Transporter-Mediated Chemoresistance: Implications for Breast Cancer Etiology and Treatment;Molecular Biotechnology;2023-12-22
5. Identification and verification of m6A-related miRNAs correlated with prognosis and immune microenvironment in colorectal cancer;Medicine;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3